Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: A study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)

Roni Bitterman, Fidi Koppel, Cristina Mussini, Yuval Geffen, Michal Chowers, Galia Rahav, Lior Nesher, Ronen Ben-Ami, Adi Turjeman, Maayan Huberman Samuel, Matthew P. Cheng, Todd C. Lee, Leonard Leibovici, Dafna Yahav, Mical Paul*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: A study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences